Received: 3 December 2019
Accepted: 5 March 2020
First Online: 27 March 2020
Ethics approval and consent to participate
: The ethical approval for the study was obtained from the Ethical Review Committee of National Institute of Cardio-Vascular Diseases (NICVD), Karachi, Pakistan (ERC-29/2018).“Study participants were enrolled after obtaining informed written consent and those study participants who were found to have either congenital heart disease or valvular heart diseases or ischemic heart disease were excluded from the study based on initial screening. Individuals who refused or shown reluctance to accept computed tomography angiography (CTA) or other laboratory assessments such as lipid profile or C-reactive protein (hs-CRP) were excluded after an initial assessment”.
: The manuscript does not contain any individual’s identifiable information or data.
: The authors declare that there are no competing interests.